Looking Beyond the Surface: A Case of Shigella Enterocolitis in a Patient Presenting With Weakness and Substance Use
Abstract
Shigella species are common causes of enteric infection, yet atypical presentations can complicate diagnosis in adults. Rising antimicrobial resistance further heightens the need for prompt and accurate identification. Atypical or non-gastrointestinal presentations remain underrecognized and risk diagnostic delay. We describe a 46-year-old man with no medical history who presented with fatigue, abdominal pain, and diarrhea following methamphetamine use. He was febrile and tachycardic with leukocytosis and elevated lactate. CT imaging demonstrated acute colitis, and stool cultures confirmed Shigella sonnei. He improved with empiric intravenous piperacillin-tazobactam and was transitioned to oral levofloxacin based on susceptibilities. This case illustrates the diagnostic challenges posed by unreliable histories, substance use, and non-specific presentations. Early imaging and stool diagnostics were key to timely management. As antimicrobial resistance among Shigella species continues to rise, maintaining a broad differential and guiding therapy with culture and susceptibility data remains essential.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Ferulic acid regulates the AKT/GSK-3β/CRMP-2 signaling pathway in a middle cerebral artery occlusion animal model
- Novel Pharmacokinetic/Pharmacodynamic Parameters Quantify the Exposure–Effect Relationship of Levofloxacin against Fluoroquinolone-Resistant Escherichia coli
- Photochemical behavior of levofloxacin
- Correlation Between Dissolution Profiles of Salt-Form Drugs in Biorelevant Bicarbonate Buffer and Oral Drug Absorption: Importance of Dose/ Fluid Volume Ratio
- Evaluation of the synergistic potential and mechanisms of action for de novo designed cationic antimicrobial peptides
- Synthesis of [11C]levofloxacin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.